Marla Shapiro-M

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Fezolinetant compared with elinzanetant for the treatment of vasomotor symptoms associated with menopause: A matching-adjusted indirect comparison.

Fezolinetant compared with elinzanetant for the treatment of vasomotor symptoms associated with menopause: A matching-adjusted indirect comparison.

Journal: Maturitas

Published: July 30, 2025

Early onset, maintenance of effect, and day-/night-time findings following fezolinetant treatment for moderate to severe vasomotor symptoms associated with menopause: A pooled phase 3 analysis.

Early onset, maintenance of effect, and day-/night-time findings following fezolinetant treatment for moderate to severe vasomotor symptoms associated with menopause: A pooled phase 3 analysis.

Journal: Maturitas

Published: May 06, 2025

Efficacy and safety of fezolinetant for moderate-severe vasomotor symptoms associated with menopause in individuals unsuitable for hormone therapy: phase 3b randomised controlled trial.

Efficacy and safety of fezolinetant for moderate-severe vasomotor symptoms associated with menopause in individuals unsuitable for hormone therapy: phase 3b randomised controlled trial.

Journal: BMJ (Clinical research ed.)

Published: November 18, 2024

Effect of fezolinetant on patient-reported quality-of-life outcomes: Data from a phase 3b study (DAYLIGHT) of the treatment of moderate to severe vasomotor symptoms associated with menopause in women considered unsuitable for hormone therapy.

Effect of fezolinetant on patient-reported quality-of-life outcomes: Data from a phase 3b study (DAYLIGHT) of the treatment of moderate to severe vasomotor symptoms associated with menopause in women considered unsuitable for hormone therapy.

Journal: Maturitas

Published: July 19, 2024

Effect of fezolinetant on sleep disturbance and impairment during treatment of vasomotor symptoms due to menopause.

Effect of fezolinetant on sleep disturbance and impairment during treatment of vasomotor symptoms due to menopause.

Journal: Maturitas

Published: November 09, 2023

A retrospective observational study of osteoporosis management after a fragility fracture in primary care.

A retrospective observational study of osteoporosis management after a fragility fracture in primary care.

Journal: Archives of osteoporosis

Published: December 01, 2021

Update on herpes zoster vaccination: a family practitioner's guide.

Update on herpes zoster vaccination: a family practitioner's guide.

Journal: Canadian family physician Medecin de famille canadien

Published: October 15, 2011

Life in the balance: my journey with breast cancer.

Life in the balance: my journey with breast cancer.

Journal: Salud publica de Mexico

Published: December 08, 2009

Showing 1-8 of 8

Last Updated: 09/26/2026